What is Acadia Pharmaceuticals's PEG ratio?

Acadia Pharmaceuticals (ACAD) reported PEG ratio of 0.2× in Q1 2026.

What does PEG ratio mean?

The P/E ratio divided by the trailing-twelve-month net-income growth rate (in percentage points). Adjusts the earnings multiple for the pace of earnings growth.

Acadia Pharmaceuticals ACAD PEG ratio

PEG ratio at other companies

BiogenBIIB

0.4×—

Neurocrine BiosciencesNBIX

0.2×—

Catalyst PharmaceuticalCPRX

1.1×+1.1×

TG TherapeuticsTGTX

0×—

AlkermesALKS

8.9×+8.6×

Jazz PharmaceuticalsJAZZ

0.3×—

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.87B+37.0%

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Calculated from Acadia Pharmaceuticals’s reported figures.

market cap/net income=0.2×

Based on the most recent quarter.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's peg ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's PEG ratio?: Acadia Pharmaceuticals (ACAD) reported PEG ratio of 0.2× in Q1 2026.
What does PEG ratio mean?: The P/E ratio divided by the trailing-twelve-month net-income growth rate (in percentage points). Adjusts the earnings multiple for the pace of earnings growth.